Document is current
Any future updates will be listed below
-
Authors
Ravanfar, Parsa
Rushmore, R. Jarrett
Lyall, Amanda E.
Cropley, Vanessa
Makris, Nikos
Desmond, Patricia
Velakoulis, Dennis
Shenton, Martha E.
Bush, Ashley I.
Rossell, Susan L.
Pantelis, Christos
Syeda, Warda T.
Phillipou, Andrea
-
Funding
Funding for this research was provided by:
University of Melbourne (Melbourne Research Scholarship)
National Institute of Mental Health (R01MH112748, 1K01MH115247-01A1, 5 U01MH109977)
Brain and Behavior Research Foundation (Young Investigator Award)
Brigham and Women's Hospital (Department of Psychiatry Internal Funding Award)
National Health and Medical Research Council (1177370, 1194028, GNT1154651, 1196508, GNT1159953)
University of Melbourne Dame Kate Campbell Fellowship
National Institutes of Health (R01MH125860)
- License Information
-
More Information
Article History
Received: 3 June 2023
Accepted: 14 August 2023
First Online: 21 August 2023
Declarations
:
: This study was granted ethics approval by the Human Research Ethics Committee (HREC) at The Melbourne Clinic (TMC REC 263), and expedited ethics approval from Swinburne’s Human Research Ethics Committee (SUHREC 2016/152). Written informed consent was obtained from all participants.
: A.I.B. is a shareholder in Alterity Ltd, Cogstate Ltd and Mesoblast Ltd. He is a paid consultant for, and has a profit share interest in, Collaborative Medicinal Development Pty Ltd.
